[1]
M. Shojaee, B. Feizi, R. Miri, J. Etemadi, and A. H. Feizi, “Intravenous Amiodarone versus Digoxin in Atrial Fibrillation Rate Control; a Clinical Trial”, Arch Acad Emerg Med, vol. 5, no. 1, p. e29, Jan. 2017.